3-Methyl-2-(piperidin-4-yloxy)pyridine dihydrochloride

Catalog No.: 
ACBYWX310
CAS No.: 
1795395-89-9
Molecular Formula: 
C11H18Cl2N2O
Molecular Weight: 
265.18
3-Methyl-2-(piperidin-4-yloxy)pyridine dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$123.00InquiryInquiry
100mg95%$173.00InquiryInquiry
250mg95%$241.00InquiryInquiry
1g95%$570.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Methyl-2-(piperidin-4-yloxy)pyridine dihydrochloride
IUPAC Name3-methyl-2-(piperidin-4-yloxy)pyridine dihydrochloride
MDL No.MFCD28118494
Molecular FormulaC11H18Cl2N2O
Molecular Weight265.18
SMILESCC1=CC=CN=C1OC2CCNCC2.[H]Cl.[H]Cl
InChI KeyREOVEHLXYBTFRN-UHFFFAOYSA-N
Synonym3-methyl-2-(piperidin-4-yloxy)pyridine dihydrochloride;3-Methyl-2-(4-piperidinyloxy)-pyridine 2HCl
CAS No.1795395-89-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACBYWX310 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLHKQ650 route compound structure diagram
    ACLHKQ65018368-76-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBYWX310 route product structure diagram
    ACBYWX3101795395-89-9
Inquiry

2. ACBYWX310 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBYWX310 route product structure diagram
    ACBYWX3101795395-89-9
Inquiry

3. ACBYWX310 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBYWX310 route product structure diagram
    ACBYWX3101795395-89-9
Inquiry

Comments (0)